![Edward Conner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward Conner
Direttore Tecnico/Scientifico/R&S presso THIRD HARMONIC BIO, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Edward Conner
Società | Posizione | Inizio | Fine |
---|---|---|---|
THIRD HARMONIC BIO, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2022 | - |
Storia della carriera di Edward Conner
Precedenti posizioni note di Edward Conner
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMARA | Direttore/Membro del Consiglio | 22/04/2020 | 24/02/2023 |
Independent Dir/Board Member | 22/04/2020 | 24/02/2023 | |
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/07/2021 | 01/06/2022 |
AUDENTES THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 15/05/2019 | - |
Corporate Officer/Principal | - | 01/07/2021 | |
SANGAMO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2016 | 31/05/2019 |
ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2015 | 01/10/2016 |
BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2013 | 01/11/2014 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | 01/01/2013 |
Formazione di Edward Conner
The University of California, San Francisco | Doctorate Degree |
Duke University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
Chief Tech/Sci/R&D Officer | 6 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
THIRD HARMONIC BIO, INC. | Health Technology |
Aziende private | 4 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Astellas Gene Therapies, Inc.
![]() Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Imara, Inc.
![]() Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
- Borsa valori
- Insiders
- Edward Conner
- Esperienza